Preparation and Evaluation of a Time-Controlled Release Capsule Made of Ethylcellulose for Colon Delivery of Drugs
- 1 January 1995
- journal article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 3 (2) , 83-89
- https://doi.org/10.3109/10611869509059209
Abstract
A novel ethylcellulose (EC) capsule which releases drug with a time-controlled fashion has been prepared. This capsule is composed of four parts, drug container, swellable substance, capsule body and cap. At the bottom of the body, micropores are made. As water penetrates through these micropores, the swellable substance such as low substituted hydroxypropyl cellulose (L-HPC) swells. When the cap made of water-insoluble macromolecular substance such as EC cannot persist the swelling pressure, the EC cap disintegrates and the drug in the container is released from the capsule. The lag-time is utilized for the delivery of drug to the colon. The release time of the drug from the capsule was measured both in vitro and in vivo experiments. In the case of an in vitro experiment, after 12mg of fluorescein as a model drug and 238mg of starch were filled into the container, caps having different thickness were attached to the capsule body and release study was performed. The release time of the drug was mainly dependent on the thickness of the cap. Using test capsules of which mean cap thickness were 39.1 +/- 2.3 (SE)microns, 63.1 +/- 5.0 microns and 75.6 +/- 4.1 microns, the in vivo release time was estimated after administration to beagle dogs. As a parameter, the peak time (tmax) when plasma fluorescein concentration reached to its maximum level was determined for the estimation of the release time of the drug from the capsule in the gastrointestinal tract. The in vivo tmax was well correlated with the cap thickness.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 23 references indexed in Scilit:
- An in vitro investigation into the suitability of pH-dependent polymers for colonic targetingInternational Journal of Pharmaceutics, 1993
- Formulation concerns of protein drugsDrug Development and Industrial Pharmacy, 1992
- Oral Delivery of VaccinesClinical Pharmacokinetics, 1992
- (B) Mechanisms of peptide and protein absorptionAdvanced Drug Delivery Reviews, 1991
- Effect of pH, Dietary Proteins and Trypsin Inhibitors on the Hydrolytic Rate of Human Granulocyte Colony-Stimulating Factor (G-CSF) by Rat Digestive Enzymes.Journal of Pharmacobio-Dynamics, 1991
- The controlled parenteral delivery of polypeptides and proteinsInternational Journal of Pharmaceutics, 1990
- Is recombinant human granulocyte colony-stimulating factor(G-CSF) orally available in rats?CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Granulocyte colony‐stimulating factor and differentiation‐induction in myeloid leukemic cellsThe International Journal of Cell Cloning, 1987
- A New Approach to the Oral Administration of Insulin and Other Peptide DrugsScience, 1986
- Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factorNature, 1986